Meet the Cell Shuttle
A factory-in-a-box for industrial scale cell therapy manufacturing.
“Cellares’ revolutionary technology will be a game changer for the cell therapy industry!”
Carl June, MD
Professor in Immunotherapy
University of Pennsylvania
Cellares Advisory Board Member
It’s Time to Automate
The potential of cell therapy is proven, but its impact is limited by manufacturing bottlenecks. Currently, there is no scalable manufacturing solution for cell therapies and existing processes are disjointed, cost prohibitive, failure prone and unable to meet market demand.
Cell Therapy Manufacturing Market by 2030
Source: Roots Analysis
Clinical Trials Underway
Source: Alliance for Regenerative Medicine
Of the Required Manufacturing Capacity Exists Today
Source: Kineticos Life Sciences
Taking on the Challenge
Cellares revolutionary technology is robust, cost-effective and will enable the parallel production of thousands of cell therapy doses per month. We’re saving lives by delivering safe and affordable access to novel cell therapies for patients in need.
True walk-away, end-to-end automation from loading the starting material to unloading a cell therapy product ready for administration.
Modular hardware supports the vast majority of cell therapy applications, including CAR-T, TCR, NK and HSC based workflows. A purpose-built process design software puts the power to define manufacturing workflows at your fingertips.
The first manufacturing platform that scales from high-throughput preclinical work to commercial scale, empowering you to meet market demand for your drug.
Three-fold reduction in process failure rates through elimination of operator error and contamination during open transfer steps.
Up to 70% cost reduction compared to open and manual manufacturing processes.
Join our Team
We are always looking for creative and passionate people to join our interdisciplinary team.
Cellares Hires Former Novartis Executive and Bristol-Myers Squibb Alum to Lead Commercialization
San Francisco, April 12, 2023 – Cellares, a biotech company…
As Cell Therapy Gains Ground, Efforts Emerge to Improve CAR T-Manufacturing
January 18th, 2023 – Cell therapy offers a treatment option for some advanced blood cancers…
Automated Manufacturing Will Deliver More—and Better—Cell Therapies
January 11th, 2023 – Cellares says automation can improve productivity…
San Francisco, April 12, 2023 - Cellares, a biotech company...
January 18th, 2023 - Cell therapy offers a treatment option for some advanced blood cancers...
January 11th, 2023 – Cellares says automation can improve productivity...